Thyroxine, methimazole, and thyroid microsomal autoantibody titres in Hypothyroid hashimoto’s thyroiditis

46Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Ten hypothyroid patients with Hashimoto’s thyroiditis were treated with methimazole 30 mg in addition to thyroxine 0-15 mg daily. Another 10 hypothyroid patients with Hashimoto’s thyroiditis were given thyroxine 015 mg alone. After 22 weeks of treatment significant decreases in thyroid microsomal autoantibody titres were observed in both groups (p <0 01). There was no difference in the mean change in titre between the two groups. When the patients treated with methimazole were subsequently given thyroxine 0 15 mg alone for a further 22 weeks no additional change in titre was observed. The data suggest that thyroxine, by normalizing serum thyroid stimulating hormone concentrations, may reduce the autoantigenic properties of the thyrocytes with a subsequent decrease in autoantibody titres. © 1985, British Medical Journal Publishing Group. All rights reserved.

Cite

CITATION STYLE

APA

Jansson, R., Karlsson, A., & Dahlberg, P. A. (1985). Thyroxine, methimazole, and thyroid microsomal autoantibody titres in Hypothyroid hashimoto’s thyroiditis. British Medical Journal (Clinical Research Ed.), 290(6461), 11–12. https://doi.org/10.1136/bmj.290.6461.11

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free